| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G-protein beta/gamma-subunit complex binding | 6.24e-05 | 25 | 62 | 3 | GO:0031683 | |
| GeneOntologyMolecularFunction | keratin filament binding | 1.41e-04 | 6 | 62 | 2 | GO:1990254 | |
| GeneOntologyMolecularFunction | deacetylase activity | 2.59e-04 | 40 | 62 | 3 | GO:0019213 | |
| GeneOntologyMolecularFunction | intermediate filament binding | 9.70e-04 | 15 | 62 | 2 | GO:0019215 | |
| GeneOntologyMolecularFunction | misfolded protein binding | 1.41e-03 | 18 | 62 | 2 | GO:0051787 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CCDC88C TMEM67 ANK1 STUB1 CLASP1 CETN3 IFT81 CKAP5 DIAPH3 MYO5C | 1.93e-03 | 1099 | 62 | 10 | GO:0008092 |
| GeneOntologyMolecularFunction | tubulin binding | 2.09e-03 | 428 | 62 | 6 | GO:0015631 | |
| GeneOntologyMolecularFunction | microtubule plus-end binding | 2.11e-03 | 22 | 62 | 2 | GO:0051010 | |
| GeneOntologyMolecularFunction | histone deacetylase activity | 2.51e-03 | 24 | 62 | 2 | GO:0004407 | |
| GeneOntologyMolecularFunction | microtubule binding | 2.67e-03 | 308 | 62 | 5 | GO:0008017 | |
| GeneOntologyMolecularFunction | protein lysine deacetylase activity | 2.72e-03 | 25 | 62 | 2 | GO:0033558 | |
| GeneOntologyMolecularFunction | R-SMAD binding | 2.94e-03 | 26 | 62 | 2 | GO:0070412 | |
| GeneOntologyMolecularFunction | NAD+-protein poly-ADP-ribosyltransferase activity | 3.40e-03 | 28 | 62 | 2 | GO:0003950 | |
| GeneOntologyMolecularFunction | NAD+-protein ADP-ribosyltransferase activity | 3.90e-03 | 30 | 62 | 2 | GO:1990404 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 3.90e-03 | 30 | 62 | 2 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 4.16e-03 | 31 | 62 | 2 | GO:0140033 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 5.48e-03 | 875 | 62 | 8 | GO:0019904 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 6.62e-03 | 123 | 62 | 3 | GO:0030165 | |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 1.77e-05 | 179 | 63 | 6 | GO:0031023 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | 3.04e-05 | 293 | 63 | 7 | GO:0032886 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | CCDC88C TMEM67 PARP1 SFPQ ANK1 STUB1 CLASP1 ERC1 VPS13C ENTR1 RBM14 CKAP5 DIAPH3 SIRT1 | 4.18e-05 | 1342 | 63 | 14 | GO:0033043 |
| GeneOntologyBiologicalProcess | microtubule depolymerization | 4.94e-05 | 66 | 63 | 4 | GO:0007019 | |
| GeneOntologyBiologicalProcess | microtubule-based process | CCDC88C TMEM67 SFPQ CLASP1 CETN3 IFT81 AP3B2 RBM14 CKAP5 KATNIP DIAPH3 SIRT1 | 7.35e-05 | 1058 | 63 | 12 | GO:0007017 |
| GeneOntologyBiologicalProcess | thyroid-stimulating hormone secretion | 9.13e-05 | 5 | 63 | 2 | GO:0070460 | |
| GeneOntologyBiologicalProcess | cellular response to heat | 1.10e-04 | 81 | 63 | 4 | GO:0034605 | |
| GeneOntologyBiologicalProcess | centrosome duplication | 1.10e-04 | 81 | 63 | 4 | GO:0051298 | |
| GeneOntologyBiologicalProcess | centrosome cycle | 1.45e-04 | 164 | 63 | 5 | GO:0007098 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule depolymerization | 2.12e-04 | 38 | 63 | 3 | GO:0007026 | |
| GeneOntologyCellularComponent | microtubule organizing center | CCDC88C TMEM67 CLASP1 ERC1 CEP112 CETN3 IFT81 ENTR1 CKAP5 GNAI2 GNAI3 DIAPH3 | 1.38e-05 | 919 | 62 | 12 | GO:0005815 |
| GeneOntologyCellularComponent | centrosome | CCDC88C TMEM67 CLASP1 ERC1 CEP112 CETN3 IFT81 ENTR1 CKAP5 GNAI2 GNAI3 | 1.44e-05 | 770 | 62 | 11 | GO:0005813 |
| GeneOntologyCellularComponent | cytoplasmic region | 9.24e-05 | 360 | 62 | 7 | GO:0099568 | |
| GeneOntologyCellularComponent | cell cortex region | 3.23e-04 | 45 | 62 | 3 | GO:0099738 | |
| Domain | CLASP_N | 7.12e-05 | 4 | 65 | 2 | PF12348 | |
| Domain | CLASP_N_dom | 7.12e-05 | 4 | 65 | 2 | IPR024395 | |
| Domain | Gprotein_alpha_I | 3.29e-04 | 8 | 65 | 2 | IPR001408 | |
| Domain | G-alpha | 1.39e-03 | 16 | 65 | 2 | PF00503 | |
| Domain | GproteinA_insert | 1.39e-03 | 16 | 65 | 2 | IPR011025 | |
| Domain | - | 1.39e-03 | 16 | 65 | 2 | 1.10.400.10 | |
| Domain | G_alpha | 1.39e-03 | 16 | 65 | 2 | SM00275 | |
| Domain | HEAT_type_2 | 1.57e-03 | 17 | 65 | 2 | IPR021133 | |
| Domain | Gprotein_alpha_su | 1.57e-03 | 17 | 65 | 2 | IPR001019 | |
| Domain | - | 2.40e-03 | 21 | 65 | 2 | 3.30.230.10 | |
| Domain | Ribosomal_S5_D2-typ_fold_subgr | 2.63e-03 | 22 | 65 | 2 | IPR014721 | |
| Domain | Ribosomal_S5_D2-typ_fold | 6.23e-03 | 34 | 65 | 2 | IPR020568 | |
| Domain | ARM-type_fold | 6.49e-03 | 339 | 65 | 5 | IPR016024 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROK2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 3.01e-04 | 8 | 47 | 2 | M47642 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROKR2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 3.01e-04 | 8 | 47 | 2 | M47643 | |
| Pathway | REACTOME_POLB_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR | 3.01e-04 | 8 | 47 | 2 | M26901 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 3.86e-04 | 9 | 47 | 2 | M47641 | |
| Pathway | REACTOME_POLB_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR | 3.86e-04 | 9 | 47 | 2 | MM14480 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_BIFUNCTIONAL_GLYCOSYLASE | 3.86e-04 | 9 | 47 | 2 | M47829 | |
| Pathway | WP_NAD_METABOLISM_SIRTUINS_AND_AGING | 5.87e-04 | 11 | 47 | 2 | M39439 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY | 5.87e-04 | 11 | 47 | 2 | M47797 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 7.03e-04 | 12 | 47 | 2 | M47558 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 7.03e-04 | 12 | 47 | 2 | M47559 | |
| Pathway | PID_S1P_S1P4_PATHWAY | 9.65e-04 | 14 | 47 | 2 | M64 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 9.65e-04 | 14 | 47 | 2 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 9.65e-04 | 14 | 47 | 2 | M750 | |
| Pubmed | USP34 PARP1 ST13P4 LONP1 SFPQ STUB1 SUDS3 RBM14 PHAX SRSF9 SIRT1 TOP2B XAB2 | 4.11e-08 | 1014 | 65 | 13 | 32416067 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | GRIP1 CCDC88C LONP1 STUB1 ERC1 VPS13C IFT81 PDCL3 ENTR1 RBM14 CKAP5 GNAI3 | 5.36e-08 | 853 | 65 | 12 | 28718761 |
| Pubmed | UNC13B USP34 MRM3 PARP1 LONP1 SFPQ STUB1 WDR87 ENTR1 RBM14 PHAX SRSF9 SIRT1 | 9.48e-07 | 1335 | 65 | 13 | 29229926 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.46e-06 | 588 | 65 | 9 | 38580884 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MRM3 PARP1 LONP1 SFPQ SLC4A7 STUB1 CLASP1 ERC1 RBM14 CKAP5 DIAPH3 TOP2B XAB2 | 1.81e-06 | 1415 | 65 | 13 | 28515276 |
| Pubmed | FHAD1 ST13P4 LONP1 ZZZ3 STUB1 SUDS3 KRT74 ENTR1 SLU7 GFPT2 SIRT1 MYO5C FILIP1L | 2.02e-06 | 1429 | 65 | 13 | 35140242 | |
| Pubmed | RGS12 polarizes the GPSM2-GNAI complex to organize and elongate stereocilia in sensory hair cells. | 2.79e-06 | 15 | 65 | 3 | 36260679 | |
| Pubmed | 3.44e-06 | 653 | 65 | 9 | 33742100 | ||
| Pubmed | Platelet Gi protein Gαi2 is an essential mediator of thrombo-inflammatory organ damage in mice. | 3.44e-06 | 2 | 65 | 2 | 25944935 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 32732457 | ||
| Pubmed | Inhibition of G alpha i2 activation by G alpha i3 in CXCR3-mediated signaling. | 3.44e-06 | 2 | 65 | 2 | 17289675 | |
| Pubmed | Gαi2 and Gαi3 Differentially Regulate Arrest from Flow and Chemotaxis in Mouse Neutrophils. | 3.44e-06 | 2 | 65 | 2 | 26976957 | |
| Pubmed | Proteomic analyses identify ARH3 as a serine mono-ADP-ribosylhydrolase. | 3.44e-06 | 2 | 65 | 2 | 29234005 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 11073886 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 24814482 | ||
| Pubmed | Gαi2- and Gαi3-deficient mice display opposite severity of myocardial ischemia reperfusion injury. | 3.44e-06 | 2 | 65 | 2 | 24858945 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 25361036 | ||
| Pubmed | Reciprocal function of Galphai2 and Galphai3 in graft-versus-host disease. | 3.44e-06 | 2 | 65 | 2 | 18521956 | |
| Pubmed | FTY720 blocks egress of T cells in part by abrogation of their adhesion on the lymph node sinus. | 3.44e-06 | 2 | 65 | 2 | 21788441 | |
| Pubmed | A small multigene family encodes Gi signal-transduction proteins. | 3.44e-06 | 2 | 65 | 2 | 3120178 | |
| Pubmed | Targeted inactivation of Galpha(i) does not alter cardiac function or beta-adrenergic sensitivity. | 3.44e-06 | 2 | 65 | 2 | 11158953 | |
| Pubmed | Functional interplay between Parp-1 and SirT1 in genome integrity and chromatin-based processes. | 3.44e-06 | 2 | 65 | 2 | 19672559 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 39322015 | ||
| Pubmed | Gαi2 is the essential Gαi protein in immune complex-induced lung disease. | 3.44e-06 | 2 | 65 | 2 | 23225882 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 25225330 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 17296938 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 20493163 | ||
| Pubmed | PARP-1 inhibition does not restore oxidant-mediated reduction in SIRT1 activity. | 3.44e-06 | 2 | 65 | 2 | 20060806 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 17360531 | ||
| Pubmed | Gαi2- and Gαi3-specific regulation of voltage-dependent L-type calcium channels in cardiomyocytes. | 3.44e-06 | 2 | 65 | 2 | 21966394 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 3.62e-06 | 220 | 65 | 6 | 35785414 | |
| Pubmed | UNC13B USP34 PARP1 MAN1A2 STUB1 ERC1 HLA-DRA IFT81 CKAP5 RNF216 GFPT2 XAB2 | 4.05e-06 | 1285 | 65 | 12 | 35914814 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GRIP1 CCDC88C STIM2 SLC4A7 CLASP1 ERC1 CEP112 RBM14 CKAP5 PFKFB2 | 4.29e-06 | 861 | 65 | 10 | 36931259 |
| Pubmed | 4.32e-06 | 128 | 65 | 5 | 30995482 | ||
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 4.79e-06 | 231 | 65 | 6 | 36597993 | |
| Pubmed | USP34 SFPQ SLC4A7 CEP112 SBF2 SLU7 GNAI3 GFPT2 DSE TIAM2 SBNO2 | 4.92e-06 | 1084 | 65 | 11 | 11544199 | |
| Pubmed | 8.62e-06 | 551 | 65 | 8 | 34728620 | ||
| Pubmed | EMX2-GPR156-Gαi reverses hair cell orientation in mechanosensory epithelia. | 9.35e-06 | 22 | 65 | 3 | 34001891 | |
| Pubmed | Serine is the major residue for ADP-ribosylation upon DNA damage. | 1.03e-05 | 3 | 65 | 2 | 29480802 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 16962188 | ||
| Pubmed | The regulatory landscape of the human HPF1- and ARH3-dependent ADP-ribosylome. | 1.03e-05 | 3 | 65 | 2 | 34625544 | |
| Pubmed | GAP1(IP4BP)/RASA3 mediates Galphai-induced inhibition of mitogen-activated protein kinase. | 1.03e-05 | 3 | 65 | 2 | 18952607 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 23977324 | ||
| Pubmed | G(o) controls the hyperpolarization-activated current in embryonic stem cell-derived cardiocytes. | 1.03e-05 | 3 | 65 | 2 | 18156202 | |
| Pubmed | Stabilization of C5a receptor--G-protein interactions through ligand binding. | 1.03e-05 | 3 | 65 | 2 | 7962171 | |
| Pubmed | 71.67 T lymphocyte activation is accompanied by the down-regulation of three G alpha genes. | 1.03e-05 | 3 | 65 | 2 | 7656338 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 15788486 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 25517228 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 30233409 | ||
| Pubmed | The AT2 receptor selectively associates with Gialpha2 and Gialpha3 in the rat fetus. | 1.03e-05 | 3 | 65 | 2 | 8663053 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 17484771 | ||
| Pubmed | Requirement of Galphai in thymic homing and early T cell development. | 1.03e-05 | 3 | 65 | 2 | 18501427 | |
| Pubmed | A PARP1-BRG1-SIRT1 axis promotes HR repair by reducing nucleosome density at DNA damage sites. | 1.03e-05 | 3 | 65 | 2 | 31291457 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 29342363 | ||
| Pubmed | Functional reconstitution of the angiotensin II type 2 receptor and G(i) activation. | 1.03e-05 | 3 | 65 | 2 | 11055978 | |
| Pubmed | TNFAIP8: a new effector for Galpha(i) coupling to reduce cell death and induce cell transformation. | 1.03e-05 | 3 | 65 | 2 | 20607800 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 28646160 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 16207712 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 17418106 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 30836096 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 26876283 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 33087267 | ||
| Pubmed | PARP1 STIM2 SFPQ ERC1 CEP112 KRT74 IFT81 GNAI2 GNAI3 DIAPH3 TEX35 TOP2B | 1.29e-05 | 1442 | 65 | 12 | 35575683 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | USP34 PARP1 SFPQ MAN1A2 SLC4A7 CLASP1 CKAP5 RNF216 GNAI3 TOP2B RCN3 | 1.31e-05 | 1203 | 65 | 11 | 29180619 |
| Pubmed | 1.43e-05 | 78 | 65 | 4 | 28611094 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.52e-05 | 283 | 65 | 6 | 30585729 | |
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | 1.67e-05 | 604 | 65 | 8 | 37616343 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MRM3 PARP1 LONP1 STIM2 SFPQ SLC4A7 STUB1 VPS13C PDCL3 DIAPH3 SRSF9 SIRT1 | 1.87e-05 | 1496 | 65 | 12 | 32877691 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.93e-05 | 1024 | 65 | 10 | 24711643 | |
| Pubmed | Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition. | 1.97e-05 | 28 | 65 | 3 | 19596686 | |
| Pubmed | 2.00e-05 | 446 | 65 | 7 | 24255178 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 18230337 | ||
| Pubmed | Most central nervous system D2 dopamine receptors are coupled to their effectors by Go. | 2.06e-05 | 4 | 65 | 2 | 11248120 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 16628003 | ||
| Pubmed | An HPF1/PARP1-Based Chemical Biology Strategy for Exploring ADP-Ribosylation. | 2.06e-05 | 4 | 65 | 2 | 33186521 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 17635935 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 20508603 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 11771389 | ||
| Pubmed | PARP1 regulates the protein stability and proapoptotic function of HIPK2. | 2.06e-05 | 4 | 65 | 2 | 27787517 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 12297509 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 11168387 | ||
| Pubmed | ELKS1 localizes the synaptic vesicle priming protein bMunc13-2 to a specific subset of active zones. | 2.06e-05 | 4 | 65 | 2 | 28264913 | |
| Pubmed | The role of inhibitory heterotrimeric G proteins in the control of in vivo heart rate dynamics. | 2.06e-05 | 4 | 65 | 2 | 18832081 | |
| Pubmed | Rev1 contributes to proper mitochondrial function via the PARP-NAD+-SIRT1-PGC1α axis. | 2.06e-05 | 4 | 65 | 2 | 28970491 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 21931697 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 18445785 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 28145731 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 2.26e-05 | 180 | 65 | 5 | 35198878 | |
| Pubmed | DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. | 2.41e-05 | 89 | 65 | 4 | 22446626 | |
| Pubmed | Targeting the p300/NONO axis sensitizes melanoma cells to BRAF inhibitors. | 2.44e-05 | 30 | 65 | 3 | 34017080 | |
| Pubmed | 2.55e-05 | 641 | 65 | 8 | 36057605 | ||
| Pubmed | 3.14e-05 | 322 | 65 | 6 | 26514267 | ||
| Pubmed | 3.14e-05 | 660 | 65 | 8 | 32780723 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 20353610 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 12860983 | ||
| Pubmed | Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins. | 3.43e-05 | 5 | 65 | 2 | 10598579 | |
| Pubmed | Coupling of dopamine receptor subtypes to multiple and diverse G proteins. | 3.43e-05 | 5 | 65 | 2 | 10978845 | |
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 26373672 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 21228215 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 16298104 | ||
| Interaction | NIN interactions | 2.17e-06 | 359 | 65 | 9 | int:NIN | |
| Interaction | AR interactions | GRIP1 USP34 PARP1 SFPQ STUB1 SUDS3 VPS13C RBM14 GNAI3 SRSF9 SIRT1 TOP2B XAB2 MYO5C | 2.60e-06 | 992 | 65 | 14 | int:AR |
| Interaction | AGTR2 interactions | 2.11e-05 | 17 | 65 | 3 | int:AGTR2 | |
| Interaction | CNTRL interactions | 3.69e-05 | 193 | 65 | 6 | int:CNTRL | |
| Cytoband | 1p13 | 2.65e-04 | 17 | 65 | 2 | 1p13 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.03e-06 | 173 | 64 | 5 | b9dee61973559e8c2fef3f2dafd43475b386befb | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.47e-06 | 176 | 64 | 5 | 437cfc5e06416bb0fc76d1f9dc106f74e279e880 | |
| ToppCell | facs-Heart-RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-06 | 197 | 64 | 5 | 940cf1e54d7c820e04946258a8b784f35c6a144c | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.69e-06 | 198 | 64 | 5 | 5f465cf5c7493e32d9afe9e9d05757d0a95acc33 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.69e-06 | 198 | 64 | 5 | 77ce3fe1ab161c0faf8987e73a64ab61294b9255 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.93e-06 | 199 | 64 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gpr149_Islr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.27e-05 | 126 | 64 | 4 | 3539a8fdbb52d191f36dce68c38798ad4d2b491a | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Pro-B|bone_marrow / Manually curated celltypes from each tissue | 7.15e-05 | 154 | 64 | 4 | 8a8c3851888ab86ca2b13ccc042cde1fef8d88f8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gpr149_Islr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.09e-05 | 159 | 64 | 4 | c64fff8d89f84d1f5a0cc432e31f56f741162505 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-DZ_GC_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.70e-05 | 162 | 64 | 4 | 3e15b3e97a2ade86d0cb0ab15fccb9a2e2e27dd4 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.56e-05 | 166 | 64 | 4 | 7286a37b2827f3747469ffd0d76cbe81116db7ee | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.56e-05 | 166 | 64 | 4 | 7c2eee0a4f45795a956acf936b85bdb35f1b1624 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.78e-05 | 167 | 64 | 4 | 9a84f45345c75f2c8ff38a04245aadee2a26a240 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-04 | 169 | 64 | 4 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 169 | 64 | 4 | 87116c33c5ca8cb1862e103e5607b1df4d264569 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.02e-04 | 169 | 64 | 4 | 78eb70dd916724e476eabccf18fb7fcec4210308 | |
| ToppCell | MS-CD8-proli_CD4|MS / Condition, Cell_class and T cell subcluster | 1.10e-04 | 172 | 64 | 4 | 0b6dd257110b3f17fa71ab18a165b091a9d5ae9a | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 176 | 64 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-04 | 176 | 64 | 4 | 4ed73c73972334f6dc4229920205547823252fa0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.20e-04 | 176 | 64 | 4 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | B_cell_maturation-CD34+_pre-plamsa|World / Lineage and Cell class | 1.22e-04 | 177 | 64 | 4 | 3ff06100deee9bee852a52078666999a9f7beaf1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 178 | 64 | 4 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 180 | 64 | 4 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-04 | 181 | 64 | 4 | 986c036e656f24fe374807e2711cec9e3c83c892 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.36e-04 | 182 | 64 | 4 | f2a1784ffcba9b27132e0db21e574cbd8a0a6418 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 182 | 64 | 4 | f96095b81188b52db8fcfca4837129cfcd9bd7b7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.36e-04 | 182 | 64 | 4 | 16186b7a0c33caa48631962381e3ab7e5d166163 | |
| ToppCell | normal_Lung-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 1.36e-04 | 182 | 64 | 4 | 8dd79fef8f8463ad3194f9cc07c6cacf2c886304 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-04 | 184 | 64 | 4 | 23515c28e1f42aab29cef9e5b4a7f45bda7f5520 | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 1.42e-04 | 184 | 64 | 4 | b0a251030d127858e68cf164be158f209a4d720f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.45e-04 | 185 | 64 | 4 | 739260f8abebaf10a5cc49d91726278579e26170 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 185 | 64 | 4 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.51e-04 | 187 | 64 | 4 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 1.51e-04 | 187 | 64 | 4 | a3592f056e1c2f82ba325fea2ecc4dd6c6347c81 | |
| ToppCell | CF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class | 1.61e-04 | 190 | 64 | 4 | 374d8fd63c733178acab07682ed1519693efab45 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.61e-04 | 190 | 64 | 4 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 191 | 64 | 4 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.64e-04 | 191 | 64 | 4 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 191 | 64 | 4 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 191 | 64 | 4 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.67e-04 | 192 | 64 | 4 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-04 | 193 | 64 | 4 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-04 | 193 | 64 | 4 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 1.71e-04 | 193 | 64 | 4 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 194 | 64 | 4 | 48063c9fe3e12aeff0707acada1baa2f8621f093 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.74e-04 | 194 | 64 | 4 | 6af2971d83f5ad6aed16d0ceb8bfc52f3947bc10 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-04 | 194 | 64 | 4 | 48c37251518f96524807b5bd1bbc2820637666ad | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 194 | 64 | 4 | 4f31d2cf7eb37b45fefc4da5b41aac0bfdd847b3 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-04 | 194 | 64 | 4 | 7b6a34d1f8922b71dcc931421666c1822cec8345 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.74e-04 | 194 | 64 | 4 | 5c60670ec24470225fabaa6071fdb4ef6e579840 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-04 | 194 | 64 | 4 | 435406ebe626c702f7d5a99a3d68ee85aa09be95 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.77e-04 | 195 | 64 | 4 | 4b9663509cc5e3f409f6d0d37640cb301a827d98 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 195 | 64 | 4 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-DZ_GC_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-04 | 195 | 64 | 4 | bf750c516e67c45c6b511909dcff934168a7bbef | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-04 | 195 | 64 | 4 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 195 | 64 | 4 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.81e-04 | 196 | 64 | 4 | fd756b247b2d8a291e8e71bec6f1e463d6557536 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-04 | 196 | 64 | 4 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.81e-04 | 196 | 64 | 4 | c9fb81a0578db6d278b8582d7b3add6c407e6dcf | |
| ToppCell | COVID-19_Mild-cDC|COVID-19_Mild / Disease condition and Cell class | 1.84e-04 | 197 | 64 | 4 | 09045845891de79164124afb6c632e2838906006 | |
| ToppCell | Monocytes-cDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.84e-04 | 197 | 64 | 4 | 3388c104af4c6a05988e102627e0c5e34d9dcc45 | |
| ToppCell | COVID-19_Mild-cDC-|COVID-19_Mild / Disease condition and Cell class | 1.84e-04 | 197 | 64 | 4 | 61d6dd023b2ba2bc76f17c06f7c30434ed865171 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-Treg|ICU-NoSEP / Disease, condition lineage and cell class | 1.88e-04 | 198 | 64 | 4 | 1ed4dfe5565328cb0f7ef31e6b2f67dfbdf3e2ac | |
| ToppCell | severe-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.92e-04 | 199 | 64 | 4 | 17283d75a2a900369f63ed02996e7ede97f46140 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-04 | 199 | 64 | 4 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-OPC_related-Oligodendrocyte/OPC|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.95e-04 | 200 | 64 | 4 | 4db894cfb80fd1f9e01133f345eefd78edd4bc43 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-OPC_related|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.95e-04 | 200 | 64 | 4 | d46a19274c2836ce7494790ce513764dedcadc79 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 1.95e-04 | 200 | 64 | 4 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| Disease | brain disease (implicated_via_orthology) | 6.69e-05 | 6 | 63 | 2 | DOID:936 (implicated_via_orthology) | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 1.25e-04 | 8 | 63 | 2 | DOID:1858 (implicated_via_orthology) | |
| Disease | Ceroid lipofuscinosis, neuronal 1, infantile | 2.00e-04 | 10 | 63 | 2 | C2931673 | |
| Disease | Joubert syndrome 1 | 9.18e-04 | 21 | 63 | 2 | C4551568 | |
| Disease | executive function measurement | 1.25e-03 | 376 | 63 | 5 | EFO_0009332 | |
| Disease | HIV Coinfection | 1.41e-03 | 103 | 63 | 3 | C4505456 | |
| Disease | HIV Infections | 1.41e-03 | 103 | 63 | 3 | C0019693 | |
| Disease | chloride measurement | 1.76e-03 | 29 | 63 | 2 | EFO_0009284 | |
| Disease | Familial aplasia of the vermis | 1.88e-03 | 30 | 63 | 2 | C0431399 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EHLVYKMDSEEKQFS | 146 | Q9UKF5 | |
| KSYDFFRHDNEEAMK | 86 | O60825 | |
| LEVDIDYFMKHSKDH | 1861 | P16157 | |
| EKLDAEFDHFVVDMK | 11 | Q8N8E3 | |
| ELYKKFEKEFTDHQE | 511 | Q9NSV4 | |
| KELELYKEDDMESVY | 221 | P0C7W6 | |
| AEKMSEHYKITLEDT | 166 | Q8IWF9 | |
| IFSSDYKRHDDLKEM | 31 | Q13367 | |
| HLMKYVEEEFSEIKE | 341 | P36021 | |
| EFHDVEDAETYKKML | 151 | Q96D15 | |
| VKDYAFVHMEKEADA | 111 | Q96PK6 | |
| KLMADNYEDDHFKSS | 981 | Q8IUD2 | |
| SKEDAIEHFMKLYEE | 606 | P09874 | |
| EELTYLKKSHEEEME | 216 | Q7Z3Y9 | |
| FEVKLHDNYELMKDE | 886 | Q14667 | |
| HDNYELMKDESKESA | 891 | Q14667 | |
| KQMKIIHEDGYSEDE | 51 | P08754 | |
| DKLPDDHYQEKTAMD | 701 | Q86WG5 | |
| EGYAKDMVTDFDEKH | 21 | O60303 | |
| DMVTDFDEKHDEYLI | 26 | O60303 | |
| EHARMKDALDYLKDF | 556 | O95786 | |
| KEKLHDVDFYKARME | 336 | Q9P219 | |
| KRTYEKDHAELMEFK | 636 | Q9Y6F6 | |
| KTYEDMTLEELEDHE | 46 | Q9H2J4 | |
| LMTEKYFKDHVEKDD | 226 | O60662 | |
| DRQHFDKEVMKAYIE | 336 | Q9BYS8 | |
| MKDLLDFADVTYEKH | 856 | Q9UL01 | |
| VLEEDHYGMEDVKKR | 486 | P36776 | |
| YNTHMADEKLEKDEI | 1596 | Q14008 | |
| HGFEEEIMEYKEQIK | 916 | B1AJZ9 | |
| ELMEAFKTLHKEYEQ | 146 | Q8WYA0 | |
| YKQDSMDLKVEFETH | 71 | O94808 | |
| ALKEKIHEYMATEDL | 721 | Q4L180 | |
| LEAKMIKEESDYHDL | 306 | Q96C92 | |
| EAKHDKYMADMDELF | 201 | Q9UNE7 | |
| DEVDMAHRFAQEYKK | 96 | Q9NX46 | |
| KDEAIDYHELKVAMR | 41 | O15182 | |
| FDGDEIFHVDMAKKE | 51 | P01903 | |
| KMYDDAIEAIEKHLI | 421 | O60476 | |
| ELHKVTLYKDSDMED | 1001 | Q9Y3R0 | |
| EHTKDLDKELDEYMH | 166 | Q9H814 | |
| DHVHKEMDYFIKDKL | 886 | Q5HYA8 | |
| FSEREHLKDKLEEYM | 181 | Q49A17 | |
| KFDYDEDASAMLKEV | 206 | Q8IZP2 | |
| MFLEEHKYFEESFKA | 526 | Q9HCS7 | |
| LMTDEIFHDVAYKAK | 491 | Q9Y6M7 | |
| EDMEYALRKLDDTKF | 156 | Q13242 | |
| TAKEAKEYFADMERH | 641 | Q02880 | |
| QRVMKFHKYEEEEDV | 311 | Q9HC36 | |
| KQMKIIHEDGYSEEE | 51 | P04899 | |
| QFHRAMKYDKDEVDL | 421 | Q96EB6 | |
| FDHLIEMDKREGKYD | 991 | Q9Y2G9 | |
| FYEQKIKEMAEHEDF | 481 | Q9NWF9 | |
| YDKTALKEAVFDDDM | 1276 | Q7Z460 | |
| KDKLESEMEDAYHEH | 516 | P23246 | |
| EEHYHLTEALKAMEK | 1271 | Q8IVF5 | |
| KMEFHISKVDELYED | 131 | Q96MK2 | |
| ESDEFIREDMKYKDA | 91 | Q9P246 | |
| KKMFHDDELEESEKF | 1886 | Q9H5I5 | |
| EEHMKIVEEYAKVDL | 176 | O95391 | |
| SSLEEIMDKAYDKFD | 736 | Q709C8 | |
| FAQDMKYALEEHEKD | 1011 | O14795 | |
| DYDEKALHELGFKDM | 1291 | Q70CQ2 | |
| DLAKHDEEDYVEMKE | 56 | Q9H7L9 | |
| LMDKDFDKLHEFVEI | 76 | Q5T0J7 | |
| EYPKNKEEDEHFLEM | 836 | Q6ZQQ6 | |
| MFLDSRKEDSYIDHK | 251 | Q8IYH5 | |
| MHYEEIALKSKAEAE | 316 | Q7RTS7 | |
| HVFKLEQEEYMKEDI | 466 | Q9NQX4 |